MetaCap

IRIDEX (IRIX) vs Nuwellis (NUWE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

IRIDEX is the larger company by market cap ($15.4 million vs $2.5 million), about 6.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

IRIX versus NUWE key metrics
MetricIRIXNUWE
Share price$0.8783$0.6907
Market cap$15.43M$2.52M
1-day change+29.16%-1.48%
YTD return-22.96%—
1-year return-20.87%—
5-year return-88.15%—
P/E ratio (TTM)—0.00
EPS (TTM)$-0.20$429.83
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.65$172.90
52-week low$0.61$0.6753
Distance from 52-week high-46.77%-99.60%
Average volume71.08K4.33M
Shares outstanding17.56M3.65M
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • IRIDEX is about 6.1 times larger than Nuwellis by market value ($15.43M vs $2.52M).

IRIX vs NUWE FAQ

Which is bigger, IRIDEX or Nuwellis?

IRIDEX (IRIX) is larger, with a market capitalization of $15.43M compared with $2.52M for Nuwellis (NUWE).

Are IRIDEX and Nuwellis in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons